Joost C M Meijers

18PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersHaematologyComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)Haematological tumoursF-block chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 02, 2023
Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior.

Joost C M Meijers, Johanneke van der Harst, Pauline F Marx

|Aug 05, 2022
In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra.

Herm Jan M Brinkman, Marleen Zuurveld, Joost C M Meijers

|Jul 11, 2022
Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen.

Awital Bar Barroeta, J Arnoud Marquart, Kamran Bakhtiari

|May 02, 2022
Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro.

Herm Jan M Brinkman, Frauke Swieringa, Marleen Zuurveld

|Mar 30, 2022
Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH.

Nicola J Mutch, Sam Walters, Elizabeth E Gardiner

|Feb 16, 2022
VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.

Marc V A van Moorsel, Geke C Poolen, Cornelis A Koekman

Pageof 3